Clinical features of unilateral acute idiopathic maculopathy identified

Article

According to a study in the Archives of Ophthalmology visual recovery of unilateral acute idiopathic maculopathy is linked with structural changes, suggesting that inflammation of the inner choroid, retinal pigment epithelium and partially reversible outer photoreceptor complex are involved in the cause of the disease.

According to a study in the Archives of Ophthalmology visual recovery of unilateral acute idiopathic maculopathy is linked with structural changes, suggesting that inflammation of the inner choroid, retinal pigment epithelium and partially reversible outer photoreceptor complex are involved in the cause of the disease.

A team led by Dr Cecilia S. Jung, Department of Vitreoretinal Surgery and Disease, Emory University, Atlanta, Georgia, USA, conducted a retrospective review on 4 unilateral acute idiopathic maculopathy patients. Clinical characteristics including age, symptoms, Snellen visual acuity and fundoscopic features were analysed. Images from spectral-domain optical coherence tomography (SD-OCT), fundus autofluorescence, fluorescein angiography and indocyanine green angiography were also evaluated.

Viral prodome, orchitis, hand-foot-mouth disease and positive coxsackievirus titers were among the associated findings present in the patients. Median visual acuity improved from 20/400 to 20/30 at follow-up, with a median follow-up time of 8 weeks.

The central macula developed irregular, circular white-grey areas of discolouration during the early stages of disease. SD-OCT presented with a partially reversible disruption of the outer photoreceptor layer.

Irregular early hyperfluorescence and late subretinal hyperfluorescence was identified with fluorescein angiography. Choroidal inflammation was found with indocyanine green angiography.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.